Filing Details
- Accession Number:
- 0001104659-22-074544
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-27 08:31:52
- Reporting Period:
- 2022-06-22
- Accepted Time:
- 2022-06-27 08:31:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chairman & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-22 | 100 | $13.10 | 2,963,714 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-23 | 200 | $11.40 | 2,963,914 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-24 | 400 | $12.18 | 2,964,314 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Includes 96,759 shares of restricted stock and 120,000 restricted stock units.
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $12.01 to $12.34. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
